XORTX Therapeutics Inc. Made Big Gain
Wed, Oct 11, 2023 at 07:25 PM
XORTX Therapeutics Inc. (XRTX:NASDAQ) rocketted at $0.39, representing a gain of 41.3%. On Wed, Oct 11, 2023, XRTX:NASDAQ hit a New 2-Week Intraday Low of $0.25. From Wed, Sep 27, 2023, the stock recorded 11.11% Up Days and 20.00% Green Days
About XORTX Therapeutics Inc. (XRTX:NASDAQ)
XORTX Therapeutics Inc is focused on developing drug therapies for orphan disease like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which...
Top 10 Gainers:
- Tempest Therapeutics Inc. (TPST:NASDAQ), 2879.17%
- Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT), 313.55%
- Phio Pharmaceuticals Corp. (PHIO:NASDAQ), 91.18%
- Tupperware Brands Corporation (TUP:NYSE), 55.33%
- Athena Consumer Acquisition Corp. Class A (ACAQ:NYSEMKT), 54.44%
- Athena Consumer Acquisition Corp. Class A (ACAQ:NYSE), 54.44%
- Asset Entities Inc. (ASST:NASDAQ), 45%
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 41.3%
- Bird Global Inc. Class A (BRDS:NYSE), 34.44%
- voxeljet AG (VJET:NASDAQ), 33.98%